
|Articles|November 15, 2003
FDA to allow inserts for keratoconus patients
Des Plaines, IL-Micro-thin prescription inserts (Intacs, Addition Technology Inc.) may be used to reduce or eliminate myopia and astigmatism in patients with keratoconus for whom restoration of functional vision is no longer possible with contact lenses or glasses, under a new designation by the FDA.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Alcon raises offer in amended deal to acquire STAAR Surgical
2
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
3
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
4
Study maps thermal dynamics of glaucoma laser treatments
5














































.png)


